174 related articles for article (PubMed ID: 15191043)
1. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment.
Thomeer MJ; Vansteenkiste J; Verbeken EK; Demedts M
Respir Med; 2004 Jun; 98(6):567-73. PubMed ID: 15191043
[TBL] [Abstract][Full Text] [Related]
2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
3. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
4. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
5. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
6. Clubbing in patients with fibrotic interstitial lung diseases.
van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
8. Influence of age on manifestation, VC and TLCO values, and bronchoalveolar lavage cell counts of sarcoidosis and extrinsic allergic alveolitis.
Sterclova M; Paluch P; Skibova J; Vasakova M
Clin Respir J; 2015 Jan; 9(1):39-44. PubMed ID: 24406019
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
10. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
11. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
12. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
13. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].
Kopiński P; Przybylski G; Jarzemska A; Sładek K; Soja J; Iwaniec T; Balicka-Slusarczyk B; Pinis G; Dyczek A; Szabłowska K; Golińska J; Jankowski M; Szczeklik J
Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824
[TBL] [Abstract][Full Text] [Related]
14. Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release.
Drent M; Jacobs JA; Cobben NA; Costabel U; Wouters EF; Mulder PG
Respir Med; 2001 Oct; 95(10):781-6. PubMed ID: 11601741
[TBL] [Abstract][Full Text] [Related]
15. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases.
Drent M; van Nierop MA; Gerritsen FA; Wouters EF; Mulder PG
Am J Respir Crit Care Med; 1996 Feb; 153(2):736-41. PubMed ID: 8564126
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
17. Comparison of alveolar septal inflammation to bronchoalveolar lavage in interstitial lung diseases.
Nagata N; Takayama K; Nikaido Y; Yokosaki Y; Kido M
Respiration; 1996; 63(2):94-9. PubMed ID: 8966373
[TBL] [Abstract][Full Text] [Related]
18. Morphometric and DNA image analysis of bronchoalveolar lavage fluid macrophages nuclei in interstitial lung diseases with lymphocytic alveolitis.
Smojver-Jezek S; Peros-Golubicić T; Tekavec-Trkanjec J; Alilović M; Vrabec-Branica B; Juros Z; Mazuranić I
Coll Antropol; 2010 Mar; 34(1):123-9. PubMed ID: 20432740
[TBL] [Abstract][Full Text] [Related]
19. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
20. [Capability of clinical and laboratory findings to predict the grade of fibrosis and the diagnosis in diffuse interstitial lung diseases].
Pérez-Padilla R; Gaxiola M; Salas J; Sansores R; Chapela R; Carrillo G; Selman M
Rev Invest Clin; 1995; 47(2):95-101. PubMed ID: 7610289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
